Dec 2 (Reuters) - Olema Pharmaceuticals OLMA.O:
OLEMA ONCOLOGY ANNOUNCES NEW CLINICAL TRIAL COLLABORATION AND SUPPLY AGREEMENT WITH NOVARTIS IN FRONTLINE METASTATIC BREAST CANCER AS WELL AS $250 MILLION EQUITY PRIVATE PLACEMENT
OLEMA PHARMACEUTICALS INC - WELL CAPITALIZED TO FUND OPERATIONS BEYOND KEY MILESTONES
Source text: ID:nGNX5SNQcx
Further company coverage: OLMA.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.